Novavax applied for EU approval for inactivated vaccine

The Amsterdam-based EU Medicines Agency (EMA) announced on Wednesday that it has already started testing and is expected to announce a decision in “a few weeks”. The vaccine is a so-called dead vaccine, which contains killed components of the novel coronavirus for immunization. (APA)